Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.

Literature DB >> 8619011

Effects of transderman nicotine on mood and sleep in nonsmoking major depressed patients.

R J Salín-Pascual¹, J R de la Fuente, L Galicia-Polo, R Drucker-Colín.

Abstract

The role of nicotine as an indirect cholinergic agent in sleep has been studied in normal subjects. There are no studies of its effects on sleep in depressed patients. Nicotine transdermal patches (17.5 mg), were studied in eight depressed patients (DSM-III-R) and eight normal volunteers. Subjects wore placebo and nicotine patches for 24 h. Depressed patients showed increased REM sleep without changes in other sleep variables. They also showed a short term improvement of mood. Normal volunteers had sleep fragmentation, and reduction of REM sleep time. No major side effects were reported in either group.

Entities: Chemical Disease Species

Mesh：

Substances：
Nicotine

Year: 1995 PMID： 8619011 DOI： 10.1007/bf02246496

Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN： 0033-3158 Impact factor: 4.530

14 in total

1. Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors: T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal: Psychiatry Clin Neurosci Date: 2001-06 Impact factor: 5.188

2. Microinjections of nicotine in the medial pontine reticular formation elicits REM sleep.

Authors: J Velazquez-Moctezuma; M D Shalauta; J C Gillin; P J Shiromani
Journal: Neurosci Lett Date: 1990-07-31 Impact factor: 3.046

3. Antinociception after nicotine administration into the mesopontine tegmentum of rats: evidence for muscarinic actions.

Authors: E T Iwamoto
Journal: J Pharmacol Exp Ther Date: 1989-11 Impact factor: 4.030

4. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats.

Authors: A Imperato; A Mulas; G Di Chiara
Journal: Eur J Pharmacol Date: 1986-12-16 Impact factor: 4.432

5. Smoking, smoking cessation, and major depression.

Authors: A H Glassman; J E Helzer; L S Covey; L B Cottler; F Stetner; J E Tipp; J Johnson
Journal: JAMA Date: 1990-09-26 Impact factor: 56.272

6. Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers.

Authors: J C Gillin; M Lardon; C Ruiz; S Golshan; R Salin-Pascual
Journal: J Clin Psychopharmacol Date: 1994-08 Impact factor: 3.153

7. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles.

Authors: M E Benwell; D J Balfour
Journal: Psychopharmacology (Berl) Date: 1979-05-08 Impact factor: 4.530

8. Nicotine dependence, major depression, and anxiety in young adults.

Authors: N Breslau; M Kilbey; P Andreski
Journal: Arch Gen Psychiatry Date: 1991-12

9. Development and use of pharmacological probes of the CNS in man: evidence of cholinergic abnormality in primary affective illness.

Authors: N Sitaram; J C Gillin
Journal: Biol Psychiatry Date: 1980-12 Impact factor: 13.382

Review 10. Catecholamines in depression: an update.

Authors: W Z Potter; H K Manji
Journal: Clin Chem Date: 1994-02 Impact factor: 8.327

28 in total

1. Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL/6J mice.

Authors: Yann S Mineur; Tenna N Mose; Sam Blakeman; Marina R Picciotto
Journal: Br J Pharmacol Date: 2017-04-08 Impact factor: 8.739

2. Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder.

Authors: Aybala Saricicek; Irina Esterlis; Kathleen H Maloney; Yann S Mineur; Barbara M Ruf; Anjana Muralidharan; Jason I Chen; Kelly P Cosgrove; Rebecca Kerestes; Subroto Ghose; Carol A Tamminga; Brian Pittman; Frederic Bois; Gilles Tamagnan; John Seibyl; Marina R Picciotto; Julie K Staley; Zubin Bhagwagar
Journal: Am J Psychiatry Date: 2012-08 Impact factor: 18.112

3. Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive Disorder.

Authors: Amy C Janes; Paola Pedrelli; Alexis E Whitton; Pia Pechtel; Samuel Douglas; Max A Martinson; Ilana Huz; Maurizio Fava; Diego A Pizzagalli; A Eden Evins
Journal: Neuropsychopharmacology Date: 2015-02-09 Impact factor: 7.853

Review 4. Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states.

Authors: Marina R Picciotto; Alan S Lewis; Gerrit I van Schalkwyk; Yann S Mineur
Journal: Neuropharmacology Date: 2015-01-09 Impact factor: 5.250

5. The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice.

Authors: R L Rabenstein; B J Caldarone; M R Picciotto
Journal: Psychopharmacology (Berl) Date: 2006-10-03 Impact factor: 4.530

6. α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties.

Authors: Yann S Mineur; Emily B Einstein; Patricia A Seymour; Jotham W Coe; Brian T O'neill; Hans Rollema; Marina R Picciotto
Journal: Behav Pharmacol Date: 2011-08 Impact factor: 2.293

10. Antidepressant-like effects of nicotine and transcranial magnetic stimulation in the olfactory bulbectomy rat model of depression.

Authors: Patricia Vieyra-Reyes; Yann S Mineur; Marina R Picciotto; Isaac Túnez; Román Vidaltamayo; René Drucker-Colín
Journal: Brain Res Bull Date: 2008-06-26 Impact factor: 4.077